264 related articles for article (PubMed ID: 35240052)
1. The relevance of T
Salvatore D; Porcelli T; Ettleson MD; Bianco AC
Lancet Diabetes Endocrinol; 2022 May; 10(5):366-372. PubMed ID: 35240052
[TBL] [Abstract][Full Text] [Related]
2. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
Jonklaas J; Burman KD
Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
[TBL] [Abstract][Full Text] [Related]
3. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
4. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.
Escobar-Morreale HF; Botella-Carretero JI; Escobar del Rey F; Morreale de Escobar G
J Clin Endocrinol Metab; 2005 Aug; 90(8):4946-54. PubMed ID: 15928247
[TBL] [Abstract][Full Text] [Related]
5. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
Livingston M; Birch K; Guy M; Kane J; Heald AH
Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
[TBL] [Abstract][Full Text] [Related]
6. Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy.
Krysiak R; Marek B; Okopień B
Endokrynol Pol; 2018; 69(1):16-22. PubMed ID: 29319127
[TBL] [Abstract][Full Text] [Related]
7. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement.
Ahluwalia R; Baldeweg SE; Boelaert K; Chatterjee K; Dayan C; Okosieme O; Priestley J; Taylor P; Vaidya B; Zammitt N; Pearce SH
Clin Endocrinol (Oxf); 2023 Aug; 99(2):206-216. PubMed ID: 37272400
[TBL] [Abstract][Full Text] [Related]
8. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
Clyde PW; Harari AE; Getka EJ; Shakir KM
JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
[TBL] [Abstract][Full Text] [Related]
9. Liothyronine use in primary hypothyroidism - current concepts.
Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3,5,3'L-triiodothyronine administration on serum thyroid hormone levels in hypothyroid patients maintained on constant doses of thyroxine.
Inada M; Nishikawa M; Naito K; Ishii H; Tanaka K; Kurata S; Oishi M; Imura H
Endocrinol Jpn; 1980 Jun; 27(3):291-5. PubMed ID: 7439119
[TBL] [Abstract][Full Text] [Related]
11. Defending plasma T3 is a biological priority.
Abdalla SM; Bianco AC
Clin Endocrinol (Oxf); 2014 Nov; 81(5):633-41. PubMed ID: 25040645
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
Hennessey JV
Endocr Pract; 2023 Jul; 29(7):572-580. PubMed ID: 37419564
[TBL] [Abstract][Full Text] [Related]
13. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.
Paone L; Fleisch AF; Feldman HA; Brown RS; Wassner AJ
J Pediatr; 2016 Aug; 175():167-172.e1. PubMed ID: 27178621
[TBL] [Abstract][Full Text] [Related]
14. [TRH refractory TSH values, triiodothyronine levels and T3/T4 quotients in hypothyroid children treated with T3/T4 preparations (author's transl)].
Hesse V; Lauterbach H; Stoll W
Klin Wochenschr; 1977 Feb; 55(3):131-5. PubMed ID: 401919
[TBL] [Abstract][Full Text] [Related]
15. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
Celi FS; Zemskova M; Linderman JD; Babar NI; Skarulis MC; Csako G; Wesley R; Costello R; Penzak SR; Pucino F
Clin Endocrinol (Oxf); 2010 May; 72(5):709-15. PubMed ID: 20447070
[TBL] [Abstract][Full Text] [Related]
16. Does combination T4 and T3 therapy make sense?
McDermott MT
Endocr Pract; 2012; 18(5):750-7. PubMed ID: 22548953
[TBL] [Abstract][Full Text] [Related]
17. Identification of Resistance to Exogenous Thyroxine in Humans.
Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
[No Abstract] [Full Text] [Related]
18. The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.
Yavuz S; Linderman JD; Smith S; Zhao X; Pucino F; Celi FS
J Clin Endocrinol Metab; 2013 May; 98(5):E862-6. PubMed ID: 23585666
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial.
Mehran L; Amouzegar A; Foroutan SM; Masoumi S; Tohidi M; Abdi H; Aghaei A; Saghafinia AE; Azizi F
BMC Endocr Disord; 2023 Aug; 23(1):182. PubMed ID: 37641049
[TBL] [Abstract][Full Text] [Related]
20. Hypothyrosis syndrome: role of triodthyronine in diagnostics and combination therapy (review of literature).
Tsanava IA; Bulgakova SV; Melikova AV
Klin Lab Diagn; 2021 May; 66(5):261-265. PubMed ID: 34047510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
